Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,268,585,398
-
Total 13F shares
-
1,014,702,612
-
Share change
-
+11,245,786
-
Total reported value
-
$65,855,218,901
-
Put/Call ratio
-
60%
-
Price per share
-
$64.97
-
Number of holders
-
1,845
-
Value change
-
+$764,515,206
-
Number of buys
-
1,007
-
Number of sells
-
759
Institutional Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q2 2020
As of 30 Jun 2020,
CVS HEALTH Corp - Common Stock (CVS) was held by
1,845 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,014,702,612 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, FMR LLC, Capital World Investors, Capital International Investors, MORGAN STANLEY, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, and NORDEA INVESTMENT MANAGEMENT AB.
This page lists
1,846
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.